Add this topic to your myFT Digest for news straight to your inbox
Research shows younger workers will open up about mental health issues — but their older colleagues still turn to alcohol
Demand for care staff is certain to rise, but providers are already failing to fill vacancies
The global health community — together with pharmaceutical companies — must prove they take maternal rights seriously
The vast amount of information held by health services makes them a prime target for cyber criminals
Record numbers used insurance for treatment in 2023
Expanded genetic profiling could lead to breakthroughs in diagnosis and therapy for common tumours, landmark global study finds
Spending on private ‘out of area’ beds has reached record levels to the detriment of financially stretched trusts and patients
Use of medication such as Novo Nordisk’s Ozempic for weight loss sparks supply fears for diabetics
Close to fivefold increase in large healthcare companies filing for Chapter 11 last year
A trial of $3 payments for getting a Covid jab in rural Ghana offers a game-changing way to meet public health goals
BMA leader signals willingness to accept 35% pay rise over ‘a number of years’
Junior doctors ready for six-day walkout in England as impasse in talks with ministers continues
Demand from China’s large ageing population coupled with advances in AI applications open a new niche
Rollout of stethoscope with pioneering technology could save lives and ease the strain on the NHS
Health service harnesses home tech to alert doctors when vulnerable patients fall ill
Americans’ interest in vaccinations has flagged despite efforts to boost uptake of latest jab
The Danish company’s drugs for obesity could have a profound impact on healthcare, society and our relationship with food
Silicon Valley group Zipline allies with trust in northern England to drop essential medical supplies
Decision sets up another potentially landmark ruling on reproductive rights as the country prepares for 2024 election
Rising premiums drive cash-strapped families to cancel coverage, fuelling fears about economic slowdown
New approach is driving a wave of mergers and acquisitions in the healthcare industry
Steady shift towards outsourcing hip, knee and eye treatment expected to expand to other procedures despite concerns
Expect earnings estimates to weaken following the FDA’s safety communication
Danish pharma group in talks with healthcare providers about innovative models to boost Wegovy take-up
Demand is soaring thanks to the NHS crisis, but providers are up against inflation and fierce competition for doctors
International Edition